- Home
- MULN vs ALBT Comparison
MULN vs ALBT Comparison
Compare MULN & ALBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MULN
- ALBT
- Stock Information
- Founded
- MULN 2014
- ALBT 2014
- Country
- MULN United States
- ALBT United States
- Employees
- MULN N/A
- ALBT N/A
- Industry
- MULN Auto Manufacturing
- ALBT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MULN Consumer Discretionary
- ALBT Health Care
- Exchange
- MULN Nasdaq
- ALBT Nasdaq
- Market Cap
- MULN 6.5M
- ALBT 5.7M
- IPO Year
- MULN N/A
- ALBT N/A
- Fundamental
- Price
- MULN $0.11
- ALBT $2.60
- Analyst Decision
- MULN
- ALBT
- Analyst Count
- MULN 0
- ALBT 0
- Target Price
- MULN N/A
- ALBT N/A
- AVG Volume (30 Days)
- MULN 49.5M
- ALBT 658.5K
- Earning Date
- MULN 08-11-2025
- ALBT 08-18-2025
- Dividend Yield
- MULN N/A
- ALBT N/A
- EPS Growth
- MULN N/A
- ALBT N/A
- EPS
- MULN N/A
- ALBT N/A
- Revenue
- MULN $8,931,612.00
- ALBT $807,235.00
- Revenue This Year
- MULN N/A
- ALBT N/A
- Revenue Next Year
- MULN N/A
- ALBT N/A
- P/E Ratio
- MULN N/A
- ALBT N/A
- Revenue Growth
- MULN 2136.62
- ALBT N/A
- 52 Week Low
- MULN $0.10
- ALBT $2.11
- 52 Week High
- MULN $132,000,000.00
- ALBT $12.60
- Technical
- Relative Strength Index (RSI)
- MULN 19.41
- ALBT 39.55
- Support Level
- MULN $0.11
- ALBT $2.54
- Resistance Level
- MULN $0.20
- ALBT $3.15
- Average True Range (ATR)
- MULN 0.11
- ALBT 0.32
- MACD
- MULN 52.73
- ALBT 0.01
- Stochastic Oscillator
- MULN 2.59
- ALBT 17.42
About MULN Mullen Automotive Inc.
Mullen Automotive Inc is engaged in manufacturing electric vehicles and building energy solutions. Its portfolio of vehicles is predominantly comprised of commercial trucks and other electric vehicles and includes; Mullen Class 1 Cargo Van, Mullen Three, Bollinger B4 Chassis Cab, and Mullen I-GO. The company's operating segments are Bollinger which derives maximum revenue, and Mullen Commercial.
About ALBT Avalon GloboCare Corp.
Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment, which is the key revenue driver, and the laboratory testing services segment. The company focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.